4.6 Article

Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade

Journal

BJU INTERNATIONAL
Volume 108, Issue 8, Pages 1256-1261

Publisher

WILEY
DOI: 10.1111/j.1464-410X.2010.09982.x

Keywords

radical prostatectomy; PSA; stage migration; grade migration

Funding

  1. German Federal Ministry of Education and Science [FKZ:01GS08189]

Ask authors/readers for more resources

OBJECTIVE To investigate the stage migration patterns during the last decade in European men treated with radical prostatectomy (RP). PATIENTS AND METHODS Between 2000 and 2009, RP was performed in 8916 patients at a single European tertiary-care institution. Age at diagnosis, clinical and pathological data were prospectively collected, and trends and proportions of preoperative and pathological findings were analysed over time. RESULTS The median (mean) age of patients increased from 62 (62) to 63 (65) years between 2000 and 2009 (P < 0.001). When patients were stratified based on their clinical findings according to the D'Amico risk groups for disease progression, the proportion of low-risk patients dropped from 66% in 2004 to 35% (P = 0.016) in the final year of the study period. Similarly, histopathological evaluation of RP specimens showed a decrease of favourable disease (organ confinement and Gleason 3 + 3 grade) from 53 to 17% (P = 0.008). This trend was accompanied by an increase in the number of patients with non-organ-confined prostate cancer (PCa) from 19% in 2003 to 33% in 2009 (P = 0.008). The restriction of the analyses in the present study to a single tertiary-care centre could limit the generalizeability of the results. CONCLUSIONS During the last decade, we observed an inverse stage migration trend in those European patients with PCa who were treated with RP. The recorded increase in patients with non-organ-confined disease after RP could be related to changes in patient selection and the growing adoption of RP in multimodal treatment settings for locally advanced tumours as well as the availability of new treatment alternatives for low-risk disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available